HOME >> BIOLOGY >> NEWS
Major breakthrough in the treatment of cancers and infectious diseases

Montreal, August 24, 2005 Dr. Andr Veillette, a researcher at the Institut de recherches cliniques de Montral (IRCM), and his team will publish in the upcoming issue of the prestigious journal Nature Immunology of Nature Publishing Group, a discovery that could significantly advance the treatment of cancers and infectious diseases. Current treatments frequently achieve only limited results with these types of diseases, which affect hundreds of thousands of Canadians.

Dr. Veillette's team identified one of the basic mechanisms controlling NK ("natural killer") cell activity. Produced by the immune system, NK cells are responsible for recognizing and killing cancer cells and cells infected by viruses such as the viruses causing hepatitis and herpes. NK cell deficiency is associated with a higher frequency of cancers and serious infections. Dr. Veillette's breakthrough demonstrates that a molecule known as EAT-2, present in NK cells, suppresses its killer function. Inhibiting EAT-2 with medications could boost NK cell activity, helping to combat cancers and infections.

This publication constitutes a significant milestone for Dr. Veillette, an internationally renowned expert in the identification of the molecular mechanisms controlling the immune system. The article, which is slated for publication online on August 28 in Nature Immunology, gives genetic evidence for the inhibiting role of EAT-2 in NK cells. It is the product of over five years of intensive research by Dr. Veillette's team.

More specifically, by studying mice in which the EAT-2 protein is eliminated through genetic manipulations, Dr. Veillette's team has established that suppressing EAT-2 results in the production of NK cells that are much more effective at killing cancer cells. Inhibiting the function of EAT-2 with medications could therefore stimulate the killer function of NK cells, and increase their capacity to destroy cancer and virus-infected cells. These medications co
'"/>

Contact: Lucette Thriault
lucette.theriault@ircm.qc.ca
514-987-5535
Institut de recherches cliniques de Montreal
28-Aug-2005


Page: 1 2

Related biology news :

1. Major breakthrough in understanding how HIV interferes with infected cell division
2. Major study predicts grim future for Europes seas
3. Major genetic study identifies clearest link yet to obesity risk
4. Major gene study uncovers secrets of leukemia
5. Major society publisher announces support for public access to scientific literature
6. Major link in brain-obesity puzzle found
7. Major Wellcome Trust award to take science from the bench to the bedside
8. Major breakthrough in the mechanism of myelin formation
9. Major new osteoporosis study to recruit people in Orkney
10. Major genetic risk factor found for prostate cancer
11. Major report on tigers to be released Thursday at National Zoo

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 17, 2019 , ... ... metabolism and distribution has been documented for many years. These observed differences may ... of adverse event profiles in patients residing in different geographic regions. This created ...
(Date:1/14/2019)... SUNNYVALE, Calif. (PRWEB) , ... January 14, 2019 ... ... a proprietary technology to detect precancer and cancer cells in blood, will present ... revealing significant advancement in the fight against colorectal cancer. The results from this ...
(Date:1/10/2019)... Va. (PRWEB) , ... January 09, 2019 , ... Dr. ... Ottawa Heart Institute in Ottawa, Ontario, Canada. He is also Director of its ... Department of Medicine, in the Department of Radiology, and in the Department of Cellular ...
Breaking Biology News(10 mins):
(Date:1/20/2019)... ... 17, 2019 , ... Consumers are directing healthcare in many ... That's changing as many services now exist for patients to order tests without ... $208 million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer ...
(Date:1/15/2019)... ... 2019 , ... Personalized treatment plans may extend life expectancy for early-stage kidney ... study published in the journal Radiology. , Kidney, or renal, tumors are often ... procedure in which the tumor and part of the kidney are removed. However, some ...
(Date:1/10/2019)... ... January 08, 2019 , ... Rascal was adopted from a local shelter when he was ... mixed breed.” Unfortunately, just six weeks after he was adopted, he tore his right ... to form in the joint after such a traumatic injury. , Sure enough, when Rascal ...
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of Gene ... named by a selection committee made up of industry leaders identified by the ASGCT ... grants are mentored awards created to support ASGCT members designing transformative pilot studies in ...
Breaking Biology Technology:
Cached News: